Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer

NCT06175390 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

RADIATION: 68Ga-FAPI-46 PET/CT
BIOLOGICAL: Tumor samples analysis
BIOLOGICAL: Blood samples analysis: Circulating Tumor DNA

Sponsor

Institut Curie

Collaborators

[object Object]